Member Login
Search

What’s New at GRAPPA

GRAPPA’s “A Patient’s Guide to Treatments for Psoriatic Arthritis”

This guide is now available free for download. It is designed for those experiencing psoriasis and/or psoriatic arthritis, and those helping to support them. Written in lay language, it explains current treatments for psoriatic disease. We also hope the guide will prove useful to health care professionals who are encouraged to provide it to their patients. The guide was written by members of GRAPPA’s patient research partner team, with support from GRAPPA’s treatment recommendations group. For those who wish to print the guide in its booklet format, the guide includes instructions on how to do this. For convenience, these instructions are also supplied in a separate pdf. To download the patient guide, please click on this icon:

GRAPPA Annual Meeting 2018 Newsletter

GRAPPA’s 2018 Annual Meeting in Toronto was one for the record books! From the research grant attendees to the scientific lectures; from the Trainee Symposium to reports on GRAPPA committee projects, from the music of the “GRAPPA Band” HEYAH!, to the changing of the guard (new president and new officers) all the news is detailed in the words and pictures of the 13-pages of the Summer/Fall GRAPPA newsletter available here.

GRAPPA Mission

GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) is organized exclusively for non-profit, educational, and scientific purposes, specifically to facilitate sharing of information related to psoriasis and psoriatic arthritis, networking among different medical disciplines that see psoriasis and psoriatic arthritis patients, and to enhance research, diagnosis and treatment of psoriasis and psoriatic arthritis.

The GRAPPA app has launched!

The GRAPPA app, available in Apple and Android formats, is free to download from the Apple store and the Google Play Store. Designed to be used by physicians, this app includes calculators for outcome measures including treat to target with the MDA criteria, the PASI and body surface area. It also has the psoriasis epidemiology screening tool (PEST) questionnaire to screen for PsA in patients with psoriasis and the PsA impact of disease (PsAID) calculator to measure both PsAID 9 and PsAID 12.

We are very grateful for grant support from AbbVie, Eli Lilly, Novartis and Pfizer which allowed GRAPPA to complete this work.

The app is free to download to all, both GRAPPA members and non-members. Here are the links:

                                    


Google Play and the Google Play logo are trademarks of Google LLC.